Search

Health care payments continue to evolve and shift away from fee‐for‐service payment systems that typically reward volume and move to value‐based payment (VBP) models that incentivize high‐quality, cost‐effective care. While this is happening more for physical health services, there's more uncertainty about the role of behavioral health. A new white paper aims to tackle that question with information about existing models that have been implemented along with recommendations for federal and state policymakers. [ABSTRACT FROM AUTHOR]

Intensive outpatient and partial hospitalization or day treatment programs can provide more intensive levels of care with multiple types of therapy, more frequent sessions with mental health professionals, and clinically informed care coordination and case management. This observation on residential treatment is included in a new white paper released this month by the National Association for Behavioral Healthcare (NABH). [ABSTRACT FROM AUTHOR]

The article focuses on the National Bureau of Economic Research (NBER) working paper from Jennifer L. Doleac and Anita Mukherjee, which found that greater opioid abuse and opioid-related crime has resulted from laws expanding access to the overdose-rescue drug naloxone. According to the study, there is no evidence that naloxone leads more people to search for fentanyl.

There have been many calls for federal changes to address the opioid epidemic, but one from Beau Kilmer, senior policy researcher and director of the Drug Policy Research Center at the RAND Corporation, released last week is a particularly interesting distillation that doesn't omit pros and cons for each strategy. [ABSTRACT FROM AUTHOR]

The primary manner by which states have been using Medicaid to expand access to substance use disorder (SUD) treatment may actually be making it more difficult for individuals to receive the services most appropriate to their needs, a newly released paper suggests. Moreover, this preferred strategy in many cases violates the law, authors with the National Health Law Program contend. [ABSTRACT FROM AUTHOR]

An over‐reliance on federal block grants and "one‐off" funding initiatives has left the addiction treatment system under‐resourced to respond to an addiction crisis that stands to be at least as deadly as COVID‐19 during the span of the Biden administration, a trio of prominent researchers argue in a newly released policy paper. The authors suggest that the new administration and Congress should prioritize efforts to build on what they consider the most impactful developments in improving access and quality in addiction treatment, such as Medicaid expansion and parity mandates. [ABSTRACT FROM AUTHOR]